- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Smoldering Multiple Myeloma (SMM) in New Zealand
Total 769 results
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)TerminatedLymphoma | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Gracell Biopharmaceuticals, Inc.RecruitingRelapsed/ Refractory Multiple MyelomaUnited States
-
Precision BioSciences, Inc.TerminatedRelapsed/Refractory Multiple MyelomaUnited States
-
PharmaMarCompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Austria, Belgium, Czechia, France, Germany, Greece, Ireland, Italy, Korea, Republic of, Netherlands, New Zealand, Poland, Portugal, Puerto Rico, Spain, Taiwan, United Kingdom
-
Sorrento Therapeutics, Inc.CompletedRelapsed or Refractory Multiple MyelomaUnited States
-
Gilead SciencesCompletedMultiple Myeloma | Myeloma, Plasma-Cell | PLASMACYTOMAUnited States
-
Genta IncorporatedCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
University of ChicagoNational Cancer Institute (NCI)RecruitingRefractory Multiple MyelomaUnited States
-
University of Maryland, BaltimoreNational Cancer Institute (NCI); University of Maryland Greenebaum Cancer CenterCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Ichnos Sciences SARecruitingRelapsed/Refractory Multiple MyelomaUnited States, Australia
-
NexImmune Inc.SuspendedRelapsed Refractory Multiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)TerminatedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Epizyme, Inc.RecruitingDiffuse Large B-Cell Lymphoma | Diffuse Large B Cell Lymphoma Refractory | Multiple Myeloma in Relapse | Multiple Myeloma, RefractoryUnited States
-
Piramal Enterprises LimitedCompletedRelapsed and/or Refractory Multiple MyelomaIndia
-
AmgenCompletedRelapsed Multiple MyelomaUnited States, Canada
-
Herbert Irving Comprehensive Cancer CenterNational Cancer Institute (NCI)UnknownMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Actinium PharmaceuticalsTerminatedRefractory Multiple MyelomaUnited States
-
Altor BioScienceNational Cancer Institute (NCI)UnknownRelapsed or Refractory Multiple MyelomaUnited States
-
Roswell Park Cancer InstituteGlaxoSmithKlineRecruiting
-
AbbVieRecruitingRelapsed/Refractory Multiple MyelomaUnited States, Australia, Israel, United Kingdom
-
Our Lady of Mercy Medical CenterUnknownLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.RecruitingRelapsed/Refractory Multiple MyelomaUnited States, France
-
New Mexico Cancer Care AllianceNovartisTerminatedMultiple Myeloma in RelapseUnited States
-
Alliance Foundation Trials, LLC.Takeda; Janssen Scientific Affairs, LLC; Celgene CorporationActive, not recruitingMyeloma, MultipleUnited States
-
Dana-Farber Cancer InstituteThe Leukemia and Lymphoma SocietyRecruitingMyelodysplastic-Myeloproliferative Diseases | Waldenstrom Macroglobulinemia | Smoldering Multiple Myeloma | Chronic Lymphocytic Leukemia (CLL) | Hematological Malignancies | Monoclonal Gammopathy of Undetermined Significance (MGUS) | B-cell Malignancy, Low-grade | Myelodysplastic Syndrome With Low-grade... and other conditionsUnited States
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...RecruitingRelapsed and/or Refractory Multiple MyelomaUnited States, France, Spain, Germany
-
Roswell Park Cancer InstituteBristol-Myers SquibbActive, not recruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Caribou Biosciences, Inc.RecruitingRelapsed/Refractory Multiple MyelomaUnited States
-
UNC Lineberger Comprehensive Cancer CenterMerck Sharp & Dohme LLC; Millennium Pharmaceuticals, Inc.; Ortho Biotech, Inc.TerminatedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Cellectis S.A.TerminatedRelapsed/Refractory Multiple MyelomaUnited States
-
AmgenTerminatedRelapsed and/or Refractory Multiple MyelomaUnited States, Japan, Belgium, Australia, Switzerland
-
Caribou Biosciences, Inc.Enrolling by invitationLymphoma | Lymphoma, Non-Hodgkin | B Cell Lymphoma | Non-Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Hematologic Malignancy | Relapsed/Refractory Multiple Myeloma | Relapsed/Refractory Acute Myeloid Leukemia | Relapsed Non-Hodgkin Lymphoma | B-Cell Non-Hodgkin's LymphomaUnited States
-
Kite, A Gilead CompanyTerminatedRelapsed/Refractory Multiple MyelomaUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)RecruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
AbbVieGenentech, Inc.CompletedRelapsed/Refractory Multiple MyelomaUnited States, Belgium, France, Norway
-
Allogene TherapeuticsActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
Weill Medical College of Cornell UniversityCelgeneCompletedMultiple MyelomaUnited States
-
Vivolux ABTheradexTerminated
-
Memorial Sloan Kettering Cancer CenterCompletedMultiple MyelomaUnited States
-
Roswell Park Cancer InstituteCompletedPlasma Cell MyelomaUnited States
-
Xencor, Inc.TerminatedRelapsed/ Refractory Multiple MyelomaUnited States, Australia
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterCelgene; Onyx/AmgenActive, not recruiting
-
Weill Medical College of Cornell UniversityCelgene CorporationTerminatedMultiple MyelomaUnited States
-
NYU Langone HealthCephalonTerminated
-
SanofiActive, not recruitingPlasma Cell MyelomaFrance, United States, Australia, Brazil, Canada, Czechia, Greece, Hungary, Italy, Japan, Korea, Republic of, New Zealand, Russian Federation, Spain, Turkey, United Kingdom
-
ORIC PharmaceuticalsRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Canada
-
Weill Medical College of Cornell UniversityTerminatedMultiple MyelomaUnited States